Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma

This study has been completed.

Study NCT00019890 Information provided by National Cancer Institute (NCI)

First Received: March 2, 2007 No Changes Posted

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given